| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.031 | 0.6 |